endpoint and Berlinger to Provide Visibility of Historical Temperature Journey of an IMP


endpoint Clinical and Berlinger & Co. AG have announced their partnership to provide complete end to end visibility of the entire temperature history of an Investigational Medicinal Product (IMP).

Our organizations understand the risks of managing temperature-controlled IMP, and therefore, we focused on designing a solution that aims to help reduce risk and eliminate the core issues. Such problems include limited transparency and missing information, the lack of immediate centralized visibility, time-consuming excursion management and slow decision making, time-consuming data consolidation for audits, wastage of drugs, and patient rescheduling or lost.

More on endpoint and Berlinger’s partnership

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.